Benjamin Hohl
CHIEF FINANCIAL OFFICER · 4 filings · Latest: Jul 17, 2026
Enliven Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ELVN | Hohl Benjamin | — | Sep 30, 2024 | Proposed Sale | $24.13 | 491 | $11.8K | — | |
ELVN | Hohl Benjamin | — | Apr 28, 2025 | Proposed Sale | $18.21 | 3,250 | $59.2K | — |
← Previous
Page 2 of 2